ArticleTransboundary and emerging diseases2022

Analysis of IgG, IgA and IgM antibodies against SARS-CoV-2 spike protein S1 in convalescent and vaccinated patients with the Pfizer-BioNTech and CanSinoBio vaccines.

Edgar A Melgoza-González et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.